Entasis Therapeutics Holdings Inc
(ETTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 15,928 | 12,741 | 13,602 | 13,297 | 12,677 |
| Operating Income | -15,928 | -12,741 | -13,602 | -13,297 | -12,677 |
| Other Income | 666 | 722 | 1,211 | 1,267 | 1,976 |
| Pre-tax Income | -15,262 | -12,019 | -12,391 | -12,030 | -10,701 |
| Net Income Continuous | -15,262 | -12,019 | -12,391 | -12,030 | -10,701 |
| Net Income | $-15,262 | $-12,019 | $-12,391 | $-12,030 | $-10,701 |
| EPS Basic Total Ops | -0.32 | -0.25 | -0.26 | -0.29 | -0.29 |
| EPS Basic Continuous Ops | -0.32 | -0.24 | -0.26 | -0.29 | -0.29 |
| EPS Diluted Total Ops | -0.32 | -0.25 | -0.26 | -0.29 | -0.29 |
| EPS Diluted Continuous Ops | -0.32 | -0.24 | -0.26 | -0.29 | -0.29 |
| EPS Diluted Before Non-Recurring Items | -0.32 | -0.25 | -0.26 | -0.29 | -0.29 |
| EBITDA(a) | $-15,904 | $-12,716 | $-13,578 | $-13,270 | $-12,649 |